MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chao, Y. S.
Right arrow Articles by Kroon, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chao, Y. S.
Right arrow Articles by Kroon, P. A.

Phenobarbital induces rat liver apolipoprotein A-I mRNA

YS Chao, CB Pickett, TT Yamin, LS Guo, AW Alberts and PA Kroon

The effect of phenobarbital on the level of rat liver apolipoprotein A- I (apo-A-I) mRNA was studied. Poly(A+)-RNA isolated from livers of control or phenobarbital-treated rats was translated in vitro in the rabbit reticulocyte lysate system and immunoprecipitated with rabbit antiserum against rat apo-A-I. The immunoprecipitate was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The translational activity of apo-A-I mRNA was estimated from the incorporation of [35S]methionine into the apo-A-I band. It was found to be elevated 4-fold by 16 hr after rats received a single injection of phenobarbital. To study the effect of phenobarbital on the level of rat liver apo-A-I mRNA, a recombinant plasmid which contained a cDNA insert corresponding to rat liver apo-A-I mRNA was isolated and used to hybridize total liver poly(A+)-RNA from control and phenobarbital- treated rats. There were 4.8- and 10-fold increases in the amount of hybridization to mRNAs from rats after they were treated with phenobarbital for 8 and 16 hr, respectively. Thus, phenobarbital increases the level of rat liver apo-A-I mRNA.

Volume 27, Issue 3, pp. 394-398, 03/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Masson, L. Lagrost, A. Athias, P. Gambert, C. Brimer-Cline, L. Lan, J. D. Schuetz, E. G. Schuetz, and M. Assem
Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid-Mediated Changes in Plasma Lipoprotein Profile
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2164 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. E. Amacher, R. Adler, A. Herath, and R. R. Townsend
Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy
Clin. Chem., October 1, 2005; 51(10): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Shibutani, N. Takahashi, T. Kobayashi, C. Uneyama, N. Masutomi, A. Nishikawa, and M. Hirose
Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay
Carcinogenesis, June 1, 2002; 23(6): 1047 - 1055.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics